申请人:SmithKline Corporation
公开号:US04206210A1
公开(公告)日:1980-06-03
A new series of lower alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines having potent central dopaminergic activity of utility in treating Parkinson's disease. The 6-and 9-methylthio compounds are particularly of use.
一系列新的具有治疗帕金森病中枢多巴胺活性的低烷基硫基-7,8-二羟基-1-苯基-2,3,4,5-四氢-1H-3-苯并哌啶类化合物。其中6-和9-甲硫基化合物特别有用。